Supplementary Table 1 from Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non–Small Cell Lung Cancer
Year: 2025
Type: supplementary-materials
Abstract: Supplementary Table 1. Key eligibility criteria
Authors: Mehmet Altan, Gilberto Lopes, T. Jeroen N. Hiltermann, Ramaswamy Govindan, Liza C. Villaruz, Emiliano Calvo, Martin J. Edelman, Muhammad Furqan, Joel Neal, Enriqueta Felip, Jennifer W. Carlisle, John V. Heymach, Róisín Eilish O’Cearbhaill, Marjorie Zauderer, Michael Chisamore, Ellie Corigliano, Ioanna Eleftheriadou, Stefan Zajic, Ben Jenkins, Sophia Goodison, Sunil Suchindran, Natalia Ramos-Hernandez, Nidale Tarek, Adam J. Schoenfeld
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4407109685